How I manage ibrutinib-refractory chronic lymphocytic leukemia

Por Woyach, Jennifer A.
Publicado no Blood (2017)

Targeted therapies in CLL: mechanisms of resistance and strategies for management

Por Woyach, Jennifer A., Johnson, Amy J.
Publicado no Blood (2015)

The B-cell receptor signaling pathway as a therapeutic target in CLL

Por Woyach, Jennifer A., Johnson, Amy J., Byrd, John C.
Publicado em 2012

Entering the Era of Targeted Therapy for Chronic Lymphocytic Leukemia: Impact on the Practicing Clinician

Por Byrd, John C., Jones, Jeffrey J., Woyach, Jennifer A., Johnson, Amy J., Flynn, Joseph M.
Publicado em 2014

Pharmacological and protein profiling suggest venetoclax (ABT-199) as optimal partner with ibrutinib in chronic lymphocytic leukemia

Por Cervantes-Gomez, Fabiola, Lamothe, Betty, Woyach, Jennifer A., Wierda, William G., Keating, Michael J., Balakrishnan, Kumudha, Gandhi, Varsha
Publicado no Clin Cancer Res (2015)

IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells

Por Dong, Shuai, Guinn, Daphne, Dubovsky, Jason A., Zhong, Yiming, Lehman, Amy, Kutok, Jeffery, Woyach, Jennifer A., Byrd, John C., Johnson, Amy J.
Publicado no Blood (2014)

Lack of Therapeutic Effect of the Histone Deacetylase Inhibitor Vorinostat in Patients with Metastatic Radioiodine-Refractory Thyroid Carcinoma

Por Woyach, Jennifer A., Kloos, Richard T., Ringel, Matthew D., Arbogast, Daria, Collamore, Minden, Zwiebel, James A., Grever, Michael, Villalona-Calero, Miguel, Shah, Manisha H.
Publicado em 2009

A Phase I/II Study of Etanercept and Rituximab in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Por Woyach, Jennifer A, Lin, Thomas S, Lucas, Margaret S, Heerema, Nyla, Moran, Mollie E., Cheney, Carolyn, Lucas, David M., Wei, Lai, Caligiuri, Michael A., Byrd, John C.
Publicado em 2009

A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLL

Por Woyach, Jennifer A., Awan, Farrukh, Flinn, Ian W., Berdeja, Jesus G., Wiley, Elizabeth, Mansoor, Sharmeen, Huang, Ying, Lozanski, Gerard, Foster, Paul A., Byrd, John C.
Publicado no Blood (2014)

Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Stu...

Por Woyach, Jennifer A., Ruppert, Amy S., Heerema, Nyla A., Peterson, Bercedis L., Gribben, John G., Morrison, Vicki A., Rai, Kanti R., Larson, Richard A., Byrd, John C.
Publicado em 2011

Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive disease

Por Woyach, Jennifer A., Heerema, Nyla A., Zhao, John, McFaddin, Andrew, Stark, Amy, Lin, Thomas S., Andritsos, Leslie A., Blum, Kristie A., Flynn, Joseph M., Jones, Jeffrey A., Byrd, John C.
Publicado em 2009

Outcome of Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Treated with Flavopiridol: Impact of Genetic Features

Por Woyach, Jennifer A., Lozanski, Gerard, Ruppert, Amy S., Lozanski, Arletta, Blum, Kristie A., Jones, Jeffrey Alan, Flynn, Joseph M., Johnson, Amy J., Grever, Michael R., Heerema, Nyla A., Byrd, John C.
Publicado em 2012

Impact of Age on Outcomes After Initial Therapy With Chemotherapy and Different Chemoimmunotherapy Regimens in Patients With Chronic Lymphocytic Leukemia: Results of Sequential Can...

Por Woyach, Jennifer A., Ruppert, Amy S., Rai, Kanti, Lin, Thomas S., Geyer, Susan, Kolitz, Jonathan, Appelbaum, Frederick R., Tallman, Martin S., Belch, Andrew R., Morrison, Vicki A., Larson, Richard A., Byrd, John C.
Publicado em 2013

The Proteasome Inhibitor Carfilzomib Functions Independently of p53 To Induce Cytotoxicity and an Atypical NF-κB Response in Chronic Lymphocytic Leukemia Cells

Por Gupta, Sneha V., Hertlein, Erin, Lu, Yanhui, Sass, Ellen J., Lapalombella, Rosa, Chen, Timothy L., Davis, Melanie E., Woyach, Jennifer A., Lehman, Amy, Jarjoura, David, Byrd, John C., Lucas, David M.
Publicado em 2013

Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia

Por Hing, Zachary A., Mantel, Rose, Beckwith, Kyle A., Guinn, Daphne, Williams, Erich, Smith, Lisa L., Williams, Katie, Johnson, Amy J., Lehman, Amy M., Byrd, John C., Woyach, Jennifer A., Lapalombella, Rosa
Publicado no Blood (2015)

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia

Por Guinn, Daphne, Lehman, Amy, Fabian, Catherine, Yu, Lianbo, Maddocks, Kami, Andritsos, Leslie A., Jones, Jeffrey A., Flynn, Joseph M., Jaglowski, Samantha M., Woyach, Jennifer A., Byrd, John C., Johnson, Amy J.
Publicado no Cancer Med (2017)

Risk Factors for Tumor Lysis Syndrome in patients with Chronic Lymphocytic Leukemia Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol

Por Blum, Kristie A., Ruppert, Amy S., Woyach, Jennifer A., Jones, Jeffrey A., Andritsos, Leslie, Flynn, Joseph M., Rovin, Brad, Villalona-Calero, Miguel, Ji, Jia, Phelps, Mitchell, Johnson, Amy J., Grever, Michael R., Byrd, John C.
Publicado em 2011

Incidence and Description of Autoimmune Cytopenias During Treatment with Ibrutinib for Chronic Lymphocytic Leukemia Autoimmune Cytopenias During Ibrutinib Treatment

Por Rogers, Kerry A., Ruppert, Amy S., Bingman, Anissa, Andritsos, Leslie A., Awan, Farrukh T., Blum, Kristie A., Flynn, Joseph M., Jaglowski, Samantha M., Lozanski, Gerard, Maddocks, Kami J., Byrd, John C., Woyach, Jennifer A., Jones, Jeffrey A.
Publicado no Leukemia (2015)

Phase I Dose Escalation Trial of the Novel Proteasome Inhibitor Carfilzomib in Patients with Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Por Awan, Farrukh T., Flynn, Joseph M., Jones, Jeffrey A., Andritsos, Leslie A., Maddocks, Kami J., Sass, Ellen J., Lucas, Margaret S., Chase, Weihong, Waymer, Sharon, Ling, Yonghua, Jiang, Yao, Phelps, Mitch A., Byrd, John C., Lucas, David M., Woyach, Jennifer A.
Publicado no Leuk Lymphoma (2015)

Targeting BTK through microRNA in chronic lymphocytic leukemia

Por Bottoni, Arianna, Rizzotto, Lara, Lai, Tzung-Huei, Liu, Chaomei, Smith, Lisa L., Mantel, Rose, Reiff, Sean, El-Gamal, Dalia, Larkin, Karilyn, Johnson, Amy J., Lapalombella, Rosa, Lehman, Amy, Plunkett, William, Byrd, John C., Blachly, James S., Woyach, Jennifer A., Sampath, Deepa
Publicado no Blood (2016)